Shari Lipner to Middle Aged
This is a "connection" page, showing publications Shari Lipner has written about Middle Aged.
Connection Strength
0.144
-
Retrospective study of nail telemedicine visits during the COVID-19 pandemic. Dermatol Ther. 2021 Jan; 34(1):e14630.
Score: 0.015
-
Retrospective study of trends in dermatology telemedicine and in-person visits at an academic center during COVID-19. J Am Acad Dermatol. 2021 Mar; 84(3):777-779.
Score: 0.015
-
Safeguarding dermatologist attendings and residents amid the COVID-19 pandemic: Focus on special populations. Dermatol Ther. 2020 Jul; 33(4):e13749.
Score: 0.014
-
Novel Use of Brimonidine 0.33% Gel for Hemostasis in Nail Surgery. Dermatol Surg. 2019 07; 45(7):993-996.
Score: 0.013
-
Retrospective single-center study evaluating clinical and dermoscopic features of longitudinal melanonychia, ABCDEF criteria, and risk of malignancy. J Am Acad Dermatol. 2019 May; 80(5):1272-1283.
Score: 0.013
-
Pharmacy costs of medications for the treatment of onychomycosis in the United States. J Am Acad Dermatol. 2019 07; 81(1):276-278.
Score: 0.013
-
A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening. J Am Acad Dermatol. 2018 Nov; 79(5):975-978.
Score: 0.012
-
Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection. J Drugs Dermatol. 2018 Feb 01; 17(2):168-172.
Score: 0.012
-
Silver Nitrate Staining of the Fingernails. J Cutan Med Surg. 2017 Sep/Oct; 21(5):443-444.
Score: 0.012
-
A retrospective study on rapid plasma reagin testing in patients with Pityriasis rosea. Int J STD AIDS. 2017 11; 28(13):1348-1351.
Score: 0.011
-
Subungual pleomorphic fibroma: a case report and review of the literature. Dermatol Online J. 2016 Nov 15; 22(11).
Score: 0.011
-
Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies. J Dermatolog Treat. 2018 Feb; 29(1):44-48.
Score: 0.003